These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23793997)

  • 1. Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
    Warnke C; Kieseier BC; Hartung HP
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S55-60. PubMed ID: 23793997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral disease-modifying treatments for multiple sclerosis: the story so far.
    Kieseier BC; Wiendl H
    CNS Drugs; 2007; 21(6):483-502. PubMed ID: 17521228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC; Wiendl H; Hemmer B; Hartung HP
    Curr Opin Neurol; 2007 Jun; 20(3):286-93. PubMed ID: 17495622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.
    Wiendl H; Kieseier BC
    Expert Opin Investig Drugs; 2003 Apr; 12(4):689-712. PubMed ID: 12665424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing symptoms of multiple sclerosis.
    Schapiro RT
    Neurol Clin; 2005 Feb; 23(1):177-87, vii. PubMed ID: 15661093
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotherapies in multiple sclerosis: a step toward remyelination and neuroprotection?
    Dubessy AL; Zujovic V; Papeix C; Stankoff B
    Rev Neurol (Paris); 2014 Dec; 170(12):770-8. PubMed ID: 25459127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of multiple sclerosis therapy.
    Kieseier BC; Wiendl H; Hartung HP; Stüve O
    Pharmacol Res; 2009 Oct; 60(4):207-11. PubMed ID: 19717009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
    Aktas O; Waiczies S; Zipp F
    J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.
    Wipfler P; Harrer A; Pilz G; Oppermann K; Trinka E; Kraus J
    Drug Discov Today; 2011 Jan; 16(1-2):8-21. PubMed ID: 21055477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA; Stadelmann C; Diem R; Bähr M; Brück W; Gold R
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):715-27. PubMed ID: 16355314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple sclerosis--symptoms, diagnosis and treatment].
    Elíasdóttir OJ; Olafsson E; Kjartansson O
    Laeknabladid; 2009 Sep; 95(9):583-9. PubMed ID: 19738293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.
    Colafrancesco V; Villoslada P
    Arch Ital Biol; 2011 Jun; 149(2):183-92. PubMed ID: 21701990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The symptomatic treatment of multiple sclerosis.
    Poser CM; Brinar VV
    Clin Neurol Neurosurg; 2002 Jul; 104(3):231-5. PubMed ID: 12127660
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis and the visual system.
    Jacobs DA; Galetta SL
    Ophthalmol Clin North Am; 2004 Sep; 17(3):265-73, v. PubMed ID: 15337188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adhesion molecules in multiple sclerosis: biology, pathogenesis and therapeutic implications.
    Archelos JJ; Hartung HP
    Mol Med Today; 1997 Jul; 3(7):310-21. PubMed ID: 9257299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL; Oksenberg JR
    Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
    Buc M
    Mediators Inflamm; 2013; 2013():963748. PubMed ID: 23766567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis.
    Blumenthal S
    Radiol Technol; 2006; 77(4):309-21, quiz 322-5. PubMed ID: 16543484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
    Stroet A; Linker RA; Gold R
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S49-53. PubMed ID: 23720188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.